Skip to content
Alclometasone dipropionate
Aclovate (alclometasone dipropionate) is a small molecule pharmaceutical. Alclometasone dipropionate was first approved as Aclovate on 1982-12-14. It is used to treat dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, and inflammation amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Alclometasone dipropionate
Tradename
Company
Number
Date
Products
ACLOVATEFougera PharmaceuticalsN-018702 DISCN1982-12-14
1 products, RLD
ACLOVATEFougera PharmaceuticalsN-018707 DISCN1982-12-14
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
alclometasone dipropionateANDA2021-04-05
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
dermatitisHP_0011123D003872L30.9
facial dermatoses—D005148—
foot dermatoses—D005533—
hand dermatoses—D006229—
inflammationMP_0001845D007249—
leg dermatoses—D007868—
scalp dermatoses—D012536—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D07: Corticosteroids, dermatological preparations
— D07A: Corticosteroid dermatological preparations, plain
— D07AB: Corticosteroids, moderately potent (group ii)
— D07AB10: Alclometasone
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01B: Antiinflammatory agents, ophthalmologic
— S01BA: Corticosteroid ophthalmologic antiinflammatory agents, plain
— S01BA10: Alclometasone
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SepsisD018805A41.9————11
BacteremiaD016470EFO_0003033R78.81————11
EndocarditisD004696EFO_0000465I33————11
Staphylococcus aureusD013211NCBITaxon_1280————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameALCLOMETASONE DIPROPIONATE
INNalclometasone
Description
Alclometasone dipropionate is a prednisolone compound having an alpha-chloro substituent at the 7-position, an alpha-methyl substituent at the 16-position and O-propanoyl groups at the 17- and 21-positions. It has a role as an anti-inflammatory drug. It is a 20-oxo steroid, an 11beta-hydroxy steroid, a glucocorticoid, a steroid ester, a propanoate ester, a 3-oxo-Delta(1),Delta(4)-steroid and a chlorinated steroid. It is functionally related to a prednisolone.
Classification
Small molecule
Drug classCorticosteroid; Glucocorticoid
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl
Identifiers
PDB—
CAS-ID66734-13-2
RxCUI17268
ChEMBL IDCHEMBL1200989
ChEBI ID31184
PubChem CID636374
DrugBankDB00240
UNII ID136H45TB7B (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 130 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
45 adverse events reported
View more details